2023
Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Ferrarotto R, Nagarajan P, Maronge J, Johnson J, Rosenthal D, Myers J, Gross N. Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngology - Head & Neck Surgery 2023, 149: 847-849. PMID: 37535378, PMCID: PMC10401391, DOI: 10.1001/jamaoto.2023.1729.Peer-Reviewed Original Research
2020
Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases
Ng S, Cardenas C, Elhalawani H, Pollard C, Elgohari B, Fang P, Meheissen M, Guha-Thakurta N, Bahig H, Johnson J, Kamal M, Garden A, Reddy J, Su S, Ferrarotto R, Frank S, Gunn G, Moreno A, Rosenthal D, Fuller C, Phan J. Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases. Physics And Imaging In Radiation Oncology 2020, 14: 1-5. PMID: 33458306, PMCID: PMC7807720, DOI: 10.1016/j.phro.2020.04.001.Peer-Reviewed Original ResearchMagnetic resonance imagingHigh interobserver agreementInterobserver agreementRe-irradiation casesSkull base sitesTumor delineationRecurrent HNCMultiple imaging modalitiesTumor volumeRadiation oncologistsResonance imagingDual energyInterobserver consistencyImaging modalitiesTreatment planningMedian DSCTomographyMagnetic resonancePatientsOncologistsTumorsDECTHead